INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5138.72M
Enterprise Value 395.8M
Trailing P/E N/A
Forward P/E 1-3.54
PEG Ratio (5 yr expected) 1-0.06
Price/Sales (ttm)23.12
Price/Book (mrq)3.04
Enterprise Value/Revenue 315.97
Enterprise Value/EBITDA 6-2.99

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-541.92%

Management Effectiveness

Return on Assets (ttm)-28.60%
Return on Equity (ttm)-59.00%

Income Statement

Revenue (ttm)6M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-14.83M
EBITDA -32.07M
Net Income Avi to Common (ttm)-30.82M
Diluted EPS (ttm)-0.59
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)49.16M
Total Cash Per Share (mrq)0.87
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.88
Book Value Per Share (mrq)0.80

Cash Flow Statement

Operating Cash Flow (ttm)-23.91M
Levered Free Cash Flow (ttm)-19.29M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.06
52-Week Change 315.38%
S&P500 52-Week Change 37.73%
52 Week High 32.92
52 Week Low 31.65
50-Day Moving Average 32.41
200-Day Moving Average 32.10

Share Statistics

Avg Vol (3 month) 3385.37k
Avg Vol (10 day) 3264.28k
Shares Outstanding 556.85M
Float 40M
% Held by Insiders 12.87%
% Held by Institutions 149.84%
Shares Short (Sep 28, 2018) 41.1M
Short Ratio (Sep 28, 2018) 42.32
Short % of Float (Sep 28, 2018) 42.62%
Short % of Shares Outstanding (Sep 28, 2018) 41.93%
Shares Short (prior month Aug 31, 2018) 41.07M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/4
Last Split Date 3Sep 13, 2006